GB201911063D0 - Formulations - Google Patents
FormulationsInfo
- Publication number
- GB201911063D0 GB201911063D0 GBGB1911063.4A GB201911063A GB201911063D0 GB 201911063 D0 GB201911063 D0 GB 201911063D0 GB 201911063 A GB201911063 A GB 201911063A GB 201911063 D0 GB201911063 D0 GB 201911063D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- formulations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1911063.4A GB201911063D0 (en) | 2019-08-02 | 2019-08-02 | Formulations |
PCT/GB2020/051844 WO2021023977A1 (en) | 2019-08-02 | 2020-07-31 | Formulations comprising corticotropin releasing hormone (crh) and alpha-2 macroglobulin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1911063.4A GB201911063D0 (en) | 2019-08-02 | 2019-08-02 | Formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201911063D0 true GB201911063D0 (en) | 2019-09-18 |
Family
ID=67990866
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1911063.4A Ceased GB201911063D0 (en) | 2019-08-02 | 2019-08-02 | Formulations |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB201911063D0 (en) |
WO (1) | WO2021023977A1 (en) |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
IL99552A0 (en) | 1990-09-28 | 1992-08-18 | Ixsys Inc | Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof |
EP1469882B1 (en) | 2002-01-28 | 2010-08-25 | Aimsco Limited | Treatment of nervous system diseases with goat serum |
BRPI0513062A (en) | 2004-07-08 | 2008-04-22 | Aimsco Ltd | pharmaceutical composition, method of stimulating pomc production in a patient, uses of an isolated crf peptide and an isolated pomc peptide, and methods of treating a disease, producing crf and curative, enhancer or prophylactic treatment of a disease |
AU2013282995B2 (en) | 2012-06-25 | 2018-10-04 | Aimsco Limited | Formulation comprising CRH and alpha - 2 - immunoglobulin |
GB201322948D0 (en) * | 2013-12-23 | 2014-02-12 | Aimsco Ltd | Improved formulation |
GB201408171D0 (en) * | 2014-05-08 | 2014-06-25 | Aimsco Ltd | Formulation and method of manufacture |
GB201617175D0 (en) * | 2016-10-10 | 2016-11-23 | Iconic Intellectual Property Limited | Assay |
-
2019
- 2019-08-02 GB GBGB1911063.4A patent/GB201911063D0/en not_active Ceased
-
2020
- 2020-07-31 WO PCT/GB2020/051844 patent/WO2021023977A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2021023977A1 (en) | 2021-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL287224A (en) | Novel formulations comprising melflufen | |
GB201707189D0 (en) | Novel formulations | |
IL285674A (en) | Pharmaceutical formulations | |
GB201707188D0 (en) | Novel formulations | |
GB201809976D0 (en) | Novel formulations | |
GB201904338D0 (en) | Fluorouracil-containing formulations | |
IL284688A (en) | Formulation | |
PT4045038T (en) | New formulations | |
IL290356A (en) | Larazotide formulations | |
IL284691A (en) | Formulations | |
GB201707187D0 (en) | Novel formulations | |
GB202018889D0 (en) | Formulations | |
GB202009684D0 (en) | Formulations | |
GB201913232D0 (en) | Aerosolisable formulation | |
SG11202010097WA (en) | Apixaban formulations | |
GB201911063D0 (en) | Formulations | |
GB201905105D0 (en) | Formulations | |
GB201910093D0 (en) | New formulations | |
GB201910092D0 (en) | New formulations | |
SG11202011823SA (en) | Activator-nucleator formulations | |
GB201819028D0 (en) | Butanol-based formulations | |
GB2587402B (en) | Formulation | |
GB201808386D0 (en) | Formulations | |
GB201804545D0 (en) | Formulations | |
GB201803201D0 (en) | Formulations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |